intravitreal implant

Data demonstrate real-world benefits of fluocinolone acetonide implantReal-world data on a fluocinolone acetonide intravitreal implant show sustained benefits of switching to the treatment in pseudophakic eyes that are insufficiently responsive to other therapies.
Dexamethasone for DME shows stronger results compared with sham groupUse of an intravitreal implant for diabetic macular edema was more effective than a sham treatment across a variety of parameters in a subanalysis of the MEAD trial.
Dexamethasone for DME delivers long-term visual benefitsA dexamethasone implant provides long-term visual improvements in patients with diabetic macular edema treated with two doses of the drug.